Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

818607

registered interest
date	08/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mefloquine
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 22 December 2017 (HL4314), whether they consider suicide, as listed in the current mefloquine product information as a psychiatric adverse reaction, to be a permanent adverse reaction.
tabling member printed	The Countess of Mar
uin	HL4484
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>Feeling suicidal, or the risk of suicide, would not be considered to be permanent adverse reactions.</p><p>Mefloquine is effective in the prevention and treatment of malaria and is approved by the Medicines and Healthcare products Regulatory Agency (MHRA), which regulates medication in the United Kingdom. As with all medicines, the MHRA keeps the safety of mefloquine under continual review. Mefloquine continues to be recommended as a safe and effective form of malaria prevention by the Advisory Committee on Malaria Prevention, the World Health Organization and other respected organisations who take account of the body of global evidence.</p> answering member printed Lord O'Shaughnessy question first answered 18/01/2018 12:23:37 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

818610

registered interest
date	08/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Levonorgestrel: Prices
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they intend to investigate the pricing of levonorgestrel by pharmacies.
tabling member printed	Lord Myners
uin	HL4487
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>The Department does not control prices of medicines sold at pharmacies without a prescription. Emergency hormonal contraception is however available free of charge on the National Health Service.</p> answering member printed Lord O'Shaughnessy question first answered 18/01/2018 12:22:42 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	3869 label Biography information for Lord Myners

818651

registered interest
date	08/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Innovative Medicines and Medical Technology Review
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the Government response to the Accelerated Access Review published in November 2017, what plans his Department has to streamline existing routes to market for medical technologies, devices and diagnostics.
tabling member constituency	East Kilbride, Strathaven and Lesmahagow
tabling member printed	Dr Lisa Cameron
uin	121415
answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>We are introducing a new Accelerated Access Pathway, to streamline regulatory and market access decisions, getting breakthrough products that we believe will be truly transformative to patients more quickly. A new Accelerated Access Collaborative (AAC) chaired by Sir Andrew Witty, will develop and own the Accelerated Access Pathway which will be operational from April 2018. All products including medical technologies, devices and diagnostics will be eligible for selection. In addition to the new Pathway, the AAC will also make recommendations to the Government and its partners about opportunities to further streamline existing routes to market.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 16/01/2018 12:04:46 answering member 4067 label Biography information for Steve Brine
tabling member	4412 label Biography information for Dr Lisa Cameron

818692

registered interest
date	08/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Phenytoin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the average cost to the public purse has been of (a) an individual prescription and (b) treating a patient with the drug Phenytoin in each of the last five years; and if he will make a statement.
tabling member constituency	Kingston upon Hull West and Hessle
tabling member printed	Emma Hardy
uin	121456
answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>The average Net Ingredient Cost (NIC) per prescription item for Phenytoin written in the United Kingdom and dispensed in England is set out below. Information is split by Phenytoin and Phenytoin Sodium with a figure provided for the total.</p><p> </p><p>Prescription items and NIC per prescription item (£)</p><table><tbody><tr><td><p> </p></td><td colspan="2"><p>Phenytoin</p></td><td colspan="2"><p>Phenytoin Sodium</p></td><td colspan="2"><p>Total</p></td></tr><tr><td><p> </p></td><td><p>Items</p></td><td><p>NIC per Item (£)</p></td><td><p>Items</p></td><td><p>NIC per Item (£)</p></td><td><p>Items</p></td><td><p>NIC per Item (£)</p></td></tr><tr><td><p>2012</p></td><td><p>39,117</p></td><td><p>15.76</p></td><td><p>970,031</p></td><td><p>21.52</p></td><td><p>1,009,148</p></td><td><p>21.30</p></td></tr><tr><td><p>2013</p></td><td><p>38,667</p></td><td><p>12.78</p></td><td><p>934,428</p></td><td><p>54.48</p></td><td><p>973,095</p></td><td><p>52.82</p></td></tr><tr><td><p>2014</p></td><td><p>36,017</p></td><td><p>12.90</p></td><td><p>894,176</p></td><td><p>48.76</p></td><td><p>930,193</p></td><td><p>47.38</p></td></tr><tr><td><p>2015</p></td><td><p>33,473</p></td><td><p>12.14</p></td><td><p>847,781</p></td><td><p>46.49</p></td><td><p>881,254</p></td><td><p>45.19</p></td></tr><tr><td><p>2016</p></td><td><p>31,360</p></td><td><p>12.16</p></td><td><p>800,820</p></td><td><p>45.19</p></td><td><p>832,180</p></td><td><p>43.94</p></td></tr></tbody></table><p>Source: Prescription Cost Analysis</p><p> </p><p>Information is not held centrally on the costs of treating a patient with phenytoin.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/01/2018 16:55:52 answering member 4067 label Biography information for Steve Brine
tabling member	4645 label Biography information for Emma Hardy

818693

registered interest
date	08/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Charles Bonnet Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what guidance GPs receive on the recognition and diagnosis of Charles Bonnet Syndrome.
tabling member constituency	Ealing Central and Acton
tabling member printed	Dr Rupa Huq
uin	121457
answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>The content and standard of training for healthcare professionals is the responsibility of training and education providers, royal colleges and professional bodies.</p><p> </p><p>It is for primary care professionals to ensure their own professional competence in regard to the recognition and diagnosis of Charles Bonnet Syndrome, and to have regard to relevant guidance published by professional bodies, voluntary sector organisations and others.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 16/01/2018 12:00:57 answering member 4067 label Biography information for Steve Brine
tabling member	4511 label Biography information for Dr Rupa Huq

818699

registered interest
date	08/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS 111
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what training is provided to the staff working on the NHS 111 service.
tabling member constituency	Mid Sussex
tabling member printed	Sir Nicholas Soames
uin	121463
answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>Initial training for call handlers within NHS 111 is an intensive training programme that spans 10 weeks in the case of call handlers, and 14 weeks in the case of clinicians. These programmes, and further information, incorporate several formal classroom-based training modules focusing on NHS Pathways use, distance learning materials, supervised practice supported by an Accredited Coach, consolidated practice and a ‘common learning programme’.</p><p> </p><p>Once call handlers and clinicians start practising independently they are then subject to on-going performance management and professional development. The terms of the NHS Pathways “Licence to Use” mandate that all staff should be audited on a monthly basis. This involves listening to ‘live’ or recorded calls which are audited using a competency based audit tool.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 11/01/2018 15:33:00 answering member 4095 label Biography information for Steve Barclay
tabling member	116 label Biography information for Lord Soames of Fletching

818752

registered interest
date	08/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Coperforma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what information his Department holds on how much was paid by NHS bodies to cover private sector liabilities to workers as a result of the performance problems with Patient Transport Services provided by Coperforma; how much money has been recovered to the public purse from Coperforma as a result of those performance problems; whether outstanding liabilities relating to that Coperforma contract will be recovered following the liquidation of Coperforma Ltd; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	121516
answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>The information requested is not collected centrally.</p><p>The provision of patient transport services is a matter for local National Health Service commissioners. NHS England has advised that High Weald Havens Clinical Commissioning Group commissioned an independent investigation into these events, which reported in March 2017. Accordingly, there are no plans to undertake a further independent investigation.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 121517 121520 question first answered 16/01/2018 16:19:44 answering member 4067 label Biography information for Steve Brine
tabling member	3930 label Biography information for Caroline Lucas

818753

registered interest
date	08/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Coperforma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will commission a formal, independent investigation into the outsourcing and performance problems of the Patient Transport Services provided by Coperforma and arms length driver operatives, including an assessment of monies paid to Coperforma and monies paid by the public sector as a result of Coperforma's performance failures; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	121517
answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>The information requested is not collected centrally.</p><p>The provision of patient transport services is a matter for local National Health Service commissioners. NHS England has advised that High Weald Havens Clinical Commissioning Group commissioned an independent investigation into these events, which reported in March 2017. Accordingly, there are no plans to undertake a further independent investigation.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 121516 121520 question first answered 16/01/2018 16:19:44 answering member 4067 label Biography information for Steve Brine
tabling member	3930 label Biography information for Caroline Lucas

818756

registered interest
date	08/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	High Weald Lewes Havens Clinical Commissioning Group
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the Answer of 8 November 2016 to Question 51429, if he will publish a copy of the validated analysis of costs provided by Coperforma Ltd to the High Weald Havens Clinical Commissioning Group referred to in that Answer; what the value is of invoices the High Weald Havens Clinical Commissioning Group received directly from each trust which incurred private ambulance costs arising from performance problems with Patient Transport Services provided by Coperforma and arms length driver operatives; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	121520
answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>The information requested is not collected centrally.</p><p>The provision of patient transport services is a matter for local National Health Service commissioners. NHS England has advised that High Weald Havens Clinical Commissioning Group commissioned an independent investigation into these events, which reported in March 2017. Accordingly, there are no plans to undertake a further independent investigation.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 121516 121517 question first answered 16/01/2018 16:19:44 answering member 4067 label Biography information for Steve Brine
tabling member	3930 label Biography information for Caroline Lucas

818775

registered interest
date	08/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Department of Health: Staff
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many staff are employed in his Department; and how many vacancies there are.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	121539
answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>As at 31 December 2017 there were 1,501 civil servants working in the Department. Vacancies are measured retrospectively and as of 30 November 2017, there were 180 vacancies in the Department. These continue to be filled.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 11/01/2018 15:31:42 answering member 4095 label Biography information for Steve Barclay
tabling member	4658 label Biography information for Alex Sobel